Updating 90Y Voxel S-Values including internal Bremsstrahlung: Monte Carlo study and development of an analytical model.
暂无分享,去创建一个
[1] L. Auditore,et al. Technical note: The contribution of internal bremsstrahlung to the 90 Y dose point kernel. , 2022, Medical physics.
[2] C. Stokke,et al. Radionuclides for Targeted Therapy: Physical Properties , 2022, Molecules.
[3] L. Auditore,et al. An analytic model to calculate voxel s-values for 177Lu , 2022, Biomedical physics & engineering express.
[4] G. Mandaglio,et al. Relevance of artefacts in 99mTc-MAA SPECT scans on pre-therapy patient-specific 90Y TARE internal dosimetry: a GATE Monte Carlo study , 2022, Physics in medicine and biology.
[5] M. Ferrari,et al. Personalized Dosimetry in Targeted Radiation Therapy: A Look to Methods, Tools and Critical Aspects , 2022, Journal of personalized medicine.
[6] G. Cheon,et al. Comparison of Voxel S-Value Methods for Personalized Voxel-based Dosimetry of 177 Lu-DOTATATE. , 2022, Medical physics.
[7] L. Strigari,et al. Overview of commercial treatment planning systems for targeted radionuclide therapy. , 2021, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[8] Lucrezia Auditore,et al. GATE Monte Carlo dosimetry in 90 Y TARE planning: influence of simulation parameters and image resampling on dosimetric accuracy and optimization of computational times , 2021 .
[9] L. Auditore,et al. Relevance of Internal Bremsstrahlung photons from 90Y decay: an experimental and Monte Carlo study. , 2021, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[10] G. Mok,et al. Recent advances in voxel-based targeted radionuclide therapy dosimetry. , 2021, Quantitative imaging in medicine and surgery.
[11] J. Martí-Climent,et al. Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods? , 2020, EJNMMI Physics.
[12] L. Auditore,et al. Enhancement of radiation exposure risk from β-emitter radionuclides due to Internal Bremsstrahlung effect: A Monte Carlo study of 90Y case. , 2020, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[13] P. Arce,et al. Full Monte Carlo internal dosimetry in nuclear medicine by means of GAMOS , 2020, Journal of Physics: Conference Series.
[14] S. Incerti,et al. Report on G4-Med, a Geant4 benchmarking system for medical physics applications developed by the Geant4 Medical Simulation Benchmarking Group. , 2020, Medical physics.
[15] A. Maier,et al. A comparison of methods for adapting 177Lu dose-voxel-kernels to tissue inhomogeneities , 2019, Physics in medicine and biology.
[16] P. Arce,et al. Internal dosimetry for TARE therapies by means of GAMOS Monte Carlo simulations. , 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[17] G. Watkins,et al. 90Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy , 2018, The Journal of Nuclear Medicine.
[18] M. Pacilio,et al. PET-CT post therapy dosimetry in radioembolization with resin 90Y microspheres: Comparison with pre-treatment SPECT-CT 99mTc-MAA results. , 2018, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[19] V. Mazzaferro,et al. Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis , 2018, BMC Cancer.
[20] S. Walrand,et al. The origin and reduction of spurious extrahepatic counts observed in 90Y non-TOF PET imaging post radioembolization , 2018, Physics in medicine and biology.
[21] Min Sun Lee,et al. Whole-Body Voxel-Based Personalized Dosimetry: The Multiple Voxel S-Value Approach for Heterogeneous Media with Nonuniform Activity Distributions , 2017, The Journal of Nuclear Medicine.
[22] P. Papadimitroulas. Dosimetry applications in GATE Monte Carlo toolkit. , 2017, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[23] A. Traino,et al. Dosimetry of non-uniform activity distribution: possibility to use the local energy deposition approach at the voxel level in radionuclide therapy , 2016 .
[24] L. V. Sá,et al. Application of GATE/Geant4 for internal dosimetry using male ICRP reference voxel phantom by specific absorbed fractions calculations for photon irradiation , 2015 .
[25] M. A. Cortés-Giraldo,et al. Recent developments in GEANT4 , 2015 .
[26] S. Marceglia,et al. Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives. , 2015, World journal of gastroenterology.
[27] Jun Zhang,et al. Theranostic Imaging of Yttrium-90 , 2015, BioMed research international.
[28] George Loudos,et al. A review of the use and potential of the GATE Monte Carlo simulation code for radiation therapy and dosimetry applications. , 2014, Medical physics.
[29] G. Glatting,et al. A fast method for rescaling voxel S values for arbitrary voxel sizes in targeted radionuclide therapy from a single Monte Carlo calculation. , 2013, Medical physics.
[30] D. Townsend,et al. Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting , 2013, EJNMMI Research.
[31] M. Pacilio,et al. An analytical method for computing voxel S values for electrons and photons. , 2012, Medical physics.
[32] Yuni K. Dewaraja,et al. MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy , 2012, The Journal of Nuclear Medicine.
[33] N. Lanconelli,et al. A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions , 2012, Physics in medicine and biology.
[34] A. Paradiso,et al. Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009). , 2011, Critical reviews in oncology/hematology.
[35] N Lanconelli,et al. Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations. , 2009, Medical physics.
[36] Michael G Stabin,et al. Uncertainties in Internal Dose Calculations for Radiopharmaceuticals , 2008, Journal of Nuclear Medicine.
[37] W. Oyen,et al. EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin) , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[38] I. Chetty,et al. Reporting and analyzing statistical uncertainties in Monte Carlo-based treatment planning. , 2006, International journal of radiation oncology, biology, physics.
[39] S. Incerti,et al. Geant4 developments and applications , 2006, IEEE Transactions on Nuclear Science.
[40] D. Visvikis,et al. GATE: a simulation toolkit for PET and SPECT , 2004, Physics in medicine and biology.
[41] P. Venkataramaiah,et al. Study of inner bremsstrahlung accompanying beta decay in 185W and 90Y , 1980 .
[42] G. W. Ford,et al. Detour transitions in internal bremsstrahlung , 1969 .
[43] I. Drozdov,et al. Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[44] B. Wessels,et al. MIRD Pamphlet No. 17: The Dosimetry of Nonuniform Activity Distributions—Radionuclide S Values at the Voxel Level , 2006 .
[45] A. Dell'Acqua,et al. Geant4—a simulation toolkit , 2003 .